| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/27/2002 | EP1190101A1 Compositions and methods for preventing transepithelial transmission of hiv |
| 03/27/2002 | EP1190086A2 Genetic modification of male germ cells for generation of transgenic species and genetic therapies |
| 03/27/2002 | EP1190084A1 Regulation system of expression using nuclear ppar receptors |
| 03/27/2002 | EP1190083A2 Dna constructs based on the eif4a gene promoter |
| 03/27/2002 | EP1190082A1 Method of inducing angiogenesis by micro-organs |
| 03/27/2002 | EP1190079A2 Control of gene expression in eukaryotic cells |
| 03/27/2002 | EP1190078A2 Nucleic acid sequences encoding proteins involved in fatty acid beta-oxidation and methods of use |
| 03/27/2002 | EP1190077A2 Genetic sequence which codes for the flavon synthase ii enzyme and use of the same |
| 03/27/2002 | EP1190074A1 Recombinant anti-cd40 antibody and uses thereof |
| 03/27/2002 | EP1190073A2 Control of gene expression |
| 03/27/2002 | EP1190072A2 22012, a novel human carboxypeptidase |
| 03/27/2002 | EP1190071A2 17867, a novel human aminopeptidase |
| 03/27/2002 | EP1190070A1 Cyclic amp phosphodiesterase isoforms and methods of use |
| 03/27/2002 | EP1190068A2 Nucleic acid sequences to proteins involved in tocopherol synthesis |
| 03/27/2002 | EP1190067A1 Process for oxidising aromatic compounds |
| 03/27/2002 | EP1190065A2 Atp binding cassette transporter protein abc1 polypeptides |
| 03/27/2002 | EP1190063A1 Nucleic and proteinic acids corresponding to human gene abc1 |
| 03/27/2002 | EP1190061A1 Streptavidin expressed gene fusions and methods of use thereof |
| 03/27/2002 | EP1190058A2 Human genes and gene expression products i |
| 03/27/2002 | EP1190057A1 Cloning and expression of a novel 5-ht4 receptor |
| 03/27/2002 | EP1190056A1 Human cytokine receptor |
| 03/27/2002 | EP1190055A2 Human endogenous retrovirus in breast cancer |
| 03/27/2002 | EP1190053A2 Mammalian calcium channels and related probes, cell lines and methods |
| 03/27/2002 | EP1190052A1 16405 receptor, a g-protein coupled receptor |
| 03/27/2002 | EP1190051A2 Human transport proteins |
| 03/27/2002 | EP1190050A2 Human transcriptional regulator proteins |
| 03/27/2002 | EP1190049A1 Spliceosome protein and its use |
| 03/27/2002 | EP1190044A2 Characterization of the yeast transcriptome |
| 03/27/2002 | EP1190042A2 Methods for manipulating the avian genome |
| 03/27/2002 | EP1189945A1 Antibodies and peptides for detection of plasmodium vivax |
| 03/27/2002 | EP1189931A2 Peptide compounds that bind her2 |
| 03/27/2002 | EP1189917A1 48 human secreted proteins |
| 03/27/2002 | EP1189635A1 Autologous adoptive immunotherapy with primed antigen-specific t cells or b cells |
| 03/27/2002 | EP1189629A2 Methods and reagents for treating glucose metabolic disorders |
| 03/27/2002 | EP1155115A4 Method of modifying cytotoxic cells and uses thereof |
| 03/27/2002 | EP1077068B1 Utilization of interferon alpha 5 in the treatment of viral hepatopathies |
| 03/27/2002 | EP1007534A4 Bh3 interacting domain death agonist |
| 03/27/2002 | EP0870018B1 Antitumour vector constructs and methods |
| 03/27/2002 | EP0733123B1 Method for detection of methylthioadenosine phosphorylase deficiency in mammalian cells |
| 03/27/2002 | CN1342206A Adenoviruses deleted in IVa2, 100K and/or preterminal protein sequences |
| 03/27/2002 | CN1342204A Methods for producing polypeptides in fungal cells |
| 03/27/2002 | CN1342202A Soluble receptor BR43X2 and methods for using them for therapy |
| 03/27/2002 | CN1342197A 蛋白质 Protein |
| 03/27/2002 | CN1342165A Neurotrophic growth factor |
| 03/27/2002 | CN1342087A Preparations stabilized over long time |
| 03/27/2002 | CN1342085A Inhibition of differentiation of cytotoxic T-cells by p-selecting ligand (PSGL) antagonists |
| 03/27/2002 | CN1341711A Notoginseng cell culture method by adding jasmone (acid) compound in culture medium |
| 03/26/2002 | US6362399 Suppression of specific classes of soybean seed protein genes |
| 03/26/2002 | US6362394 Expressing receptor polypeptide in transgenic plant cell; contacting transgenic plant cell with juvenile hormone or its agonists, wherein receptor polypeptide controls expression of target polypeptide in presence of juvenile hormone |
| 03/26/2002 | US6362393 Methods for generating doubled haploid plants |
| 03/26/2002 | US6362324 Used as target for diagnosis and treatment in aminopeptidase-related disorders such as aging, cancers, cataracts, cystic fibrosis and leukemias; used in drug-screening to identify agonists, antagonists |
| 03/26/2002 | US6362319 Glial cell line-derived neurotrophic factor |
| 03/26/2002 | US6362316 Human metabotropic glutamate receptor subtype mGluR6 protein |
| 03/26/2002 | US6362001 Establishing a culture of drosophila cells; transfecting with expressible class 1 mhc heavy chain gene linked to promoter; transfecting with an expressible .beta.-2 microglobulin gene and with assisting molecule gene, mixing with peptide |
| 03/26/2002 | US6361999 Auxinic analogues of indole-3- acetic acid |
| 03/26/2002 | US6361998 Culturing an initial population containing erythroid precursors in a serum free defined medium essentially free of fatty acids and hydrocortisone comprising serum albumin, insulin, transferrin, il-3, scf, sa and epo and recovering |
| 03/26/2002 | US6361997 Genetically modified CD34-negative adherently growing stem cells and their use in gene therapy |
| 03/26/2002 | US6361996 Capable of self-renewal and of differentiation into neurons, astrocytes, and oligodendrocytes |
| 03/26/2002 | US6361995 Protection of pancreatic β-cells during islet isolation and assessment of islet viability and candidate diabetes drugs after islet isolation |
| 03/26/2002 | US6361977 Methods of using multivariant IL-3 hematopoiesis fusion protein |
| 03/26/2002 | US6361974 Exonuclease-mediated nucleic acid reassembly in directed evolution |
| 03/26/2002 | US6361972 Compositions and methods for non-targeted activation of endogenous genes |
| 03/26/2002 | US6361970 A polypeptide encoding an isoleucyl trna synthetase; therapy and screening antibiotic compounds |
| 03/26/2002 | US6361967 Axor10, a g-protein coupled receptor |
| 03/26/2002 | US6361946 A bone marrow modulating method in mammals by adminstering a polypeptide that binds to at least one endothelial cell surface receptor to modulates myelopoiesis |
| 03/26/2002 | US6361808 Preparing alcoholic beveroge, heating, steeping or mixing |
| 03/26/2002 | US6361779 Transferrin receptor genes |
| 03/26/2002 | US6361771 Implantable cell culture device comprising semipermeable membrane permitting diffusion of growth factor therethrough, and arpe-19 cells genetically engineered to produce growth factor disposed within semipermeable membrane |
| 03/26/2002 | CA2232727C Novel variants of green fluorescent protein, gfp |
| 03/26/2002 | CA2180570C Isolated p27 protein and its encoding nucleic acid molecules |
| 03/26/2002 | CA2176834C Process for protein production in plants |
| 03/26/2002 | CA2137551C A novel endothelial cell molecule mediating lymphocyte binding in man |
| 03/26/2002 | CA1341351C Production of chimeric mouse-human antibodies with specificity to human tumor antigens |
| 03/22/2002 | CA2357526A1 Mannosidase structures |
| 03/21/2002 | WO2002023202A2 Method to identify antibody targets based on mass spectrometry (maldi-tof) |
| 03/21/2002 | WO2002022871A2 Polymorphic bone morphogenetic protein 2 |
| 03/21/2002 | WO2002022851A2 Novel tumor-associated marker |
| 03/21/2002 | WO2002022832A1 A cell line expressing mutated human tissue - type plasminogen activator, the constructing strategy thereof and method of preparing expressed protein |
| 03/21/2002 | WO2002022819A2 Calcium binding proteins |
| 03/21/2002 | WO2002022818A1 Human and rat pgc-3, ppar-gamma coactivations and splice variants thereof |
| 03/21/2002 | WO2002022809A2 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST |
| 03/21/2002 | WO2002022807A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 03/21/2002 | WO2002022806A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof |
| 03/21/2002 | WO2002022805A2 Modulation of il-2- and il-15-mediated t cell responses |
| 03/21/2002 | WO2002022802A1 Novel compounds |
| 03/21/2002 | WO2002022795A2 Isolated human kinase proteins, nucleic acid molecules and uses thereof |
| 03/21/2002 | WO2002022790A1 T cell receptor transfer into a candidate effector cell or a precursor thereof |
| 03/21/2002 | WO2002022789A1 Process for producing normal parenchymal cells, tissue or organ by bioincubator |
| 03/21/2002 | WO2002022788A1 Method of culturing mesenchymal stem cells |
| 03/21/2002 | WO2002022787A2 Differential treatment of selected parts of a single cell with different fluid components |
| 03/21/2002 | WO2002022786A1 Method and cell composition for screening compounds for anti-inflammatory activity |
| 03/21/2002 | WO2002022782A2 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 03/21/2002 | WO2002022776A2 Human coagulation factor vii variants |
| 03/21/2002 | WO2002022775A1 Bio-reactor device |
| 03/21/2002 | WO2002022684A2 Transporters and ion channels |
| 03/21/2002 | WO2002022683A1 Novel dendritic cell wall membrane and use thereof |
| 03/21/2002 | WO2002022682A1 Interferon-alpha induced gene |
| 03/21/2002 | WO2002022680A2 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine) |
| 03/21/2002 | WO2002022678A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/21/2002 | WO2002022656A2 An hsp70 peptide stimulating natural killer (nk) cell activity and uses thereof |